Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study

  • Sherief Abd-Elsalam
    Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt;
  • Eslam Saber Esmail
    Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt;
  • Mai Khalaf
    Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt;
  • Ehab Fawzy Abdo
    Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt;
  • Mohammed A. Medhat
    Department of Gastroenterology and Tropical Medicine, Faculty of Medicine, Assiut University, Assiut, Egypt;
  • Mohamed Samir Abd El Ghafar
    Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt;
  • Ossama Ashraf Ahmed
    Department of Internal Medicine, Ain-Shams University, Cairo, Egypt;
  • Shaimaa Soliman
    Public Health and Community Medicine, Menoufia University, Menoufia, Egypt;
  • Ghada N. Serangawy
    Department of Forensic Medicine and Toxicology, Faculty of Medicine, Tanta University, Tanta, Egypt;
  • Mohamed Alboraie
    Department of Internal Medicine, Al-Azhar University, Cairo, Egypt

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1360857595353683328
  • DOI
    10.4269/ajtmh.20-0873
  • ISSN
    14761645
    00029637
  • データソース種別
    • Crossref

問題の指摘

ページトップへ